Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Heres a brief timeline of their development: 2005 : Approved for treating type 2 diabetes
Your response to GLP-1 may not match the timing below
A patch that delivers only 1030% of the dose needed creates a subtherapeutic effect, leaving patients hungry and without the metabolic benefits of higher doses
Its incumbent on employers now to start navigating how to cover the drugs in the most cost-effective manner. Editors Note: Additional Content For more information and resources related to this article, see the pages below, which offer quick access to all WorldatWork content on these topics:
US$ 20.79
US$ 28.84
US$ 27.22
US$ 22.89
US$ 25.39
